Top

Obesity Surgery

Published in:

01-03-2019 | Sleeve Gastrectomy | Letter to the Editor

Letter: Celiac Disease Presenting After a Single Anastomosis Duodeno-Ileal Bypass and Sleeve Gastrectomy

Authors: Amelie Therrien, Marie-Pierre Renaud, Lilia-Maria Sanchez, Louise D’Aoust, Michel Lemoyne

Published in: Obesity Surgery | Issue 3/2019

Excerpt

Dear Editor, …

Freeman LM, Strong AT, Sharma G, et al. Implications of celiac disease among patients undergoing gastric bypass. Obes Surg. 2018;28(6):1546–52. https://doi.org/10.1007/s11695-017-3046-2.CrossRefPubMed

Jamma S, Rubio-Tapia A, Kelly CP, et al. Celiac crisis is a rare but serious complication of celiac disease in adults. Clin Gastroenterol Hepatol. 2010;8(7):587–90. https://doi.org/10.1016/j.cgh.2010.04.009.CrossRefPubMedPubMedCentral

Maple JT, Pearson RK, Murray JA, et al. Silent celiac disease activated by pancreaticoduodenectomy. Dig Dis Sci. 2007;52(9):2140–4. https://doi.org/10.1007/s10620-006-9598-y.CrossRefPubMed

Cuenca-Abente F, Nachman F, Bai JC. Diagnosis of celiac disease during pre-operative work-up for bariatric surgery. Acta Gastroenterol Latinoam. 2012;42(4):321–4.PubMed

Pane A, Orois A, Careaga M, et al. Clinical onset of celiac disease after duodenal switch: a case report. Eur J Clin Nutr. 2016;70(9):1078–9. https://doi.org/10.1038/ejcn.2016.65.CrossRefPubMed

Marini JM, Coghlan E, Laferrere L, et al. Severe malnutrition and celiac disease following gastric bypass surgery. Int J Case Reports Med. 2014;2014:1–5. https://doi.org/10.5171/2014.130992.CrossRef

Ukkola A, Maki M, Kurppa K, et al. Changes in body mass index on a gluten-free diet in coeliac disease: a nationwide study. Eur J Intern Med. 2012;23(4):384–8. https://doi.org/10.1016/j.ejim.2011.12.012.CrossRefPubMed

de Angelis N, Carra MC, Vincenzi F. Gluten-free diet in obese patients with celiac disease: an enemy of the bariatric surgeon? Obes Surg. 2012;22(6):995–6. https://doi.org/10.1007/s11695-012-0626-z.CrossRef

Shoar S, Poliakin L, Rubenstein R, et al. Single anastomosis duodeno-ileal switch (SADIS): a systematic review of efficacy and safety. Obes Surg. 2018;28(1):104–13. https://doi.org/10.1007/s11695-017-2838-8.CrossRefPubMed

10.

Puzziferri N, Roshek 3rd TB, Mayo HG, et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934–42. https://doi.org/10.1001/jama.2014.10706.CrossRefPubMedPubMedCentral

11.

Costantino G, della Torre A, Lo Presti MA, et al. Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Dig Liver Dis. 2008;40(1):74–7. https://doi.org/10.1016/j.dld.2006.10.017.CrossRefPubMed

12.

Murray JA, Rubio-Tapia A, Van Dyke CT, et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol. 2008;6(2):186–93; quiz 25. https://doi.org/10.1016/j.cgh.2007.10.012.CrossRefPubMed

13.

Hoerter NA, Shannahan SE, Suarez J, et al. Diagnostic yield of isolated deamidated gliadin peptide antibody elevation for celiac disease. Dig Dis Sci. 2017;62(5):1272–6. https://doi.org/10.1007/s10620-017-4474-5.CrossRefPubMed

14.

de Chaisemartin L, Meatchi T, Malamut G, et al. Application of deamidated gliadin antibodies in the follow-up of treated celiac disease. PLoS One. 2015;10(8):e0136745. https://doi.org/10.1371/journal.pone.0136745.CrossRefPubMedPubMedCentral

15.

Lau MS, Mooney PD, White WL, et al. The role of an IgA/IgG-deamidated gliadin peptide point-of-care test in predicting persistent villous atrophy in patients with celiac disease on a gluten-free diet. Am J Gastroenterol. 2017;112(12):1859–67. https://doi.org/10.1038/ajg.2017.357.CrossRefPubMed

16.

Tosco A, Maglio M, Paparo F, et al. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. J Pediatr Gastroenterol Nutr. 2008;47(3):293–8. https://doi.org/10.1097/MPG.0b013e3181677067.CrossRefPubMed

17.

Gatti S, Rossi M, Alfonsi S, et al. Beyond the intestinal celiac mucosa: diagnostic role of anti-TG2 deposits, a systematic review. Front Med (Lausanne). 2014;1:9. https://doi.org/10.3389/fmed.2014.00009.CrossRef

Title: Letter: Celiac Disease Presenting After a Single Anastomosis Duodeno-Ileal Bypass and Sleeve Gastrectomy
Authors: Amelie Therrien
Marie-Pierre Renaud
Lilia-Maria Sanchez
Louise D’Aoust
Michel Lemoyne
Publication date: 01-03-2019
Publisher: Springer US
Keywords: Sleeve Gastrectomy
Bariatric Surgery
Bariatric Surgery
Celiac Disease
Celiac Disease
Published in: Obesity Surgery / Issue 3/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-018-03678-3

At a glance: The STEP trials

Springer Medicine

Letter: Celiac Disease Presenting After a Single Anastomosis Duodeno-Ileal Bypass and Sleeve Gastrectomy

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2019

Revisional Gastric Bypass After Failed Adjustable Gastric Banding—One-Stage or Two-Stage Procedure?

Botox or No-Tox?

Revisional Roux-en-Y Gastric Bypass: a Safe Surgical Opportunity? Results of a Case-Matched Study

Exploring the Patient-Reported Impact of the Pharmacist on Pre-bariatric Surgical Assessment

Biography: Professor Cunchuan Wang, MD, PhD

Systematization of Nutritional Care In Endoscopic Treatment for Obesity